By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


Medical Device

Company News
Navidea Biopharmaceuticals (NAVB) Release: Lymphoseek® Performance Vs. Sulfur Colloid In Breast Cancer Patients Published In Annals Of Surgical Oncology; Fewer Nodal Dissections Required 1/29/2015 10:06:30 AM
Navidea Biopharmaceuticals (NAVB)’s Macrophage Therapeutics Unit Announces Plan For $2.5 Million Financing 1/21/2015 9:35:27 AM
Navidea Biopharmaceuticals (NAVB) To Present At Biotech Showcase 2015 1/6/2015 11:41:04 AM
Navidea Biopharmaceuticals (NAVB) Strengthens Leadership Team To Accelerate Lymphoseek® Growth 1/5/2015 9:21:32 AM
Navidea Biopharmaceuticals (NAVB) Forms Macrophage Therapeutics Business Unit To Explore Therapeutic Applications Of Manocept™ 12/10/2014 10:40:25 AM
Navidea Biopharmaceuticals (NAVB) To Present At The 2014 LD Micro Conference 11/25/2014 1:56:02 PM
European Commission (EC) Approves Navidea Biopharmaceuticals (NAVB)’s Sentinel Lymph Node Detection Agent Lymphoseek® 11/20/2014 9:11:32 AM
Navidea Biopharmaceuticals (NAVB) Receives $1.1Million PDUFA Filing Fee Refund For Award Of Orphan Drug Status; Platinum Partners Reaffirms Commitment To Line Of Credit 11/11/2014 10:42:32 AM
Navidea Biopharmaceuticals (NAVB) Announces Third Quarter 2014 Financial Results 11/6/2014 11:16:19 AM
Navidea Biopharmaceuticals (NAVB) Announces Scientific Presentations Of Results From Lymphoseek® Studies At The European Association Of Nuclear Medicine And European Society Of Surgical Oncology Meetings 10/30/2014 10:08:10 AM